Forte Biosciences Inc. Stock
Heavy losses for Forte Biosciences Inc. today as the stock fell by -€0.120 (-4.960%).
With 7 Buy predictions and not the single Sell prediction the community is currently very high on Forte Biosciences Inc..
With a target price of €21.00 there is potential for a 821.053% increase which would mean more than doubling the current price of €2.28 for Forte Biosciences Inc..
Our community identified positive and negative aspects for Forte Biosciences Inc. stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Forte Biosciences Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Forte Biosciences Inc. in the next few years
Pros
0
-
Cons
6
Probably not worthwhile Investment
2
Dependend from some customers or products
1
Little known brand
Performance of Forte Biosciences Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Forte Biosciences Inc. | -4.960% | -5.785% | -20.833% | -93.275% | -92.233% | - | - |
| Clovis Oncology Inc. | -2.230% | -0.560% | -1.582% | -19.465% | 2.387% | -79.381% | -88.027% |
| Biocryst Pharmaceuticals | -0.480% | -3.218% | -4.137% | 289.214% | 123.145% | 125.536% | 202.660% |
| Champions Oncology Inc | -0.580% | -0.578% | -4.972% | 13.158% | -4.972% | - | - |
Comments
Other discussions about Forte Biosciences Inc. Stock
Trading Tocagen
Trading Tocagen
